1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Taidoc Technology Corporation

Taidoc Technology Corporation

TTWSE:4736
131.50
TWD
+1.00
(+0.77%)
26.64EPS
4.30P/E
10.63BMarket Cap
Nov 11Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
33.07
35.33
34.63
40.64
42.7
54.8
50.08
66.27
70.18
102.54
50.42
48.66
44.08
43.34
Basic EPS, GAAP
4.92
5.99
5.85
6.32
5.43
11.05
8.03
17.08
21.35
36.03
10.67
12.15
15.12
26.28
Free Cash Flow per Basic Share
3.68
6.2
2.21
5.49
4.46
-3.3
9.42
11.66
17.22
28.78
11.1
6.49
6.31
6.71
Dividend per Share
2.72
4.25
4.26
4.58
4.53
4.79
7.24
6.62
11.46
14.88
19.99
10
9.71
3.88
Book Value per Share
28.9
32.76
36.25
38.02
38.97
47.64
51.98
69.75
79.52
101.52
93.33
95.26
102.6
117.05
Tangible Book Value per Share
28.8
32.64
36.19
37.97
38.84
47.57
51.92
69.7
79.45
101.46
93.27
95.22
102.55
116.96
Basic Weighted Avg Shares
70
71
76
77
78
79
83
89
93
94
95
95
95
98
Sales/Revenue/Turnover
2,304
2,521
2,637
3,148
3,345
4,347
4,138
5,904
6,493
9,627
4,807
4,641
4,204
4,228
Operating Margin (%)
10.3
18.83
17.74
19.96
18.95
24.42
22.01
31.94
32.59
43.7
20.35
17.35
22.16
17.89
Depreciation Expense
162
163
171
198
205
195
212
235
220
232
232
172
144
142
Net Income, GAAP
343
428
445
489
425
877
664
1,521
1,975
3,383
1,017
1,159
1,442
2,565
Effective Tax Rate (%)
12.58
18.06
13.25
17.93
25.84
18.13
18.38
20.49
18.61
20.59
20.71
17.94
14.06
8.17
Profit Margin (%)
14.87
16.96
16.88
15.54
12.71
20.17
16.04
25.77
30.42
35.14
21.17
24.97
34.3
60.65
Working Capital
1,225
1,062
1,896
1,738
1,081
1,503
2,698
3,275
3,453
5,461
4,807
4,962
5,192
6,011
LT Debt
590
- -
581
586
444
931
1,854
746
313
298
250
214
181
163
Total Equity
2,113
2,489
2,914
3,076
3,179
4,023
4,511
6,621
7,635
9,995
9,259
9,523
10,124
11,359
Return on Invested Capital (%)
7.78
12.43
11.22
12.77
9.72
13.62
9.74
21.35
20.12
32.1
7.02
6.29
7.45
6.13
Return on Capital (%)
14.08
14.5
12.89
12.1
8.6
15.09
10.12
20.5
23.29
33.88
9.45
10.78
13.16
22.71
Return on Common Equity (%)
17.7
19.34
16.98
16.84
14.1
25.31
16.1
28.18
28.58
39.66
10.96
12.88
15.28
26.17

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
979
979
778
LT Borrowings
178
169
161
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
95
95
94
Market Capitalization
10,525
10,525
10,634

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
7,573
7,744
8,755
Cash, Cash Equivalents & STI
5,226
5,363
6,255
Accounts Receivable, Net
912
913
952
Inventories
1,267
1,276
1,350
Total Current Liabilities
2,381
2,835
2,744
Payables & Accruals
- -
- -
- -
ST Debt
979
979
778
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.24%
9.61%
6.32%
Free Cash Flow
-38.6%
3.58%
-2.76%
Net Income, GAAP
27.74%
13.9%
24.43%
Sales/Revenue/Turnover
8.88%
-0.94%
-9.41%
Total Cash Common Dividend
16.76%
19%
-2.94%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,078
1,163
1,232
1,167
4,641
2025
977
1,121
1,078
1,028
4,204
2026
1,074
1,048
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4.24
2.81
1.03
3.69
12.15
2025
-0.16
4.9
6.43
3.58
15.12
2026
2.99
13.66
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10
2025
- -
- -
- -
3.6
9.71
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Chao-Wang Chen
Full Time Employees
654
Sector
Health technology
Industry
Medical specialties
Address
No. 127, Wugong 2nd Road Taipei TP Taiwan 24888
IPO Date
Sep 26, 2008
Website
taidoc.com.tw
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
TaiDoc Technology Corporation (4736.TWO), a Taiwan-based original equipment manufacturer and original design manufacturer of medical equipment, develops and markets diagnostic test equipment and reagents, home care devices, professional medical monitoring equipment, and telemedicine products. Core offerings include blood glucose monitoring systems, blood pressure monitors, multiple parameter monitoring systems encompassing blood glucose, ketone bodies, cholesterol, uric acid, and glycated hemoglobin; point-of-care testing devices, lancet and lancing devices, nebulizers, ear and forehead thermometers, vital sign monitors, pulse oximeters, veterinary health care products such as blood glucose, calcium, and ketone meters; telehealth remote monitoring devices with Bluetooth, Wi-Fi, and GPRS connectivity linked to smartphone applications including MyLink, ProCheck, Healthy Check, Healthy Check PRO, and PCLink; Covid-19 antigen rapid test kits; and regulatory consulting, clinical suggestions, engineering resources, and manufacturing services. The company, founded in 1998 and headquartered at No. 127, Wugong 2nd Road, Wugu District, New Taipei City, Taiwan, operates internationally with approximately 829 employees and focuses on home care, diagnostics, professional instruments, and telehealth solutions for consumers, healthcare professionals, and veterinary markets. TaiDoc listed on the Taiwan Stock Exchange in 2010 and maintains steady operations without reported major acquisitions, funding rounds, partnerships, or strategic shifts in the last one to two years.